👀 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Is The Risk Of Corruption Worth Doing Business In China?

Published 02/12/2014, 12:04 PM
Updated 02/12/2014, 03:25 PM
Is The Risk Of Corruption Worth Doing Business In China?

By Sophie Song - Doing business is tricky in China, the newest survey of international companies says, and as much as 25 percent of those surveyed avoided doing business in China altogether for fear of corruption.  

The survey, which was conducted by international business advisers AlixPartners and covered China for the first time, interviewed lawyers and executives of multinationals involved in compliance and found 25 percent avoided China and the Middle East for fear of corruption, while 39 percent avoided Africa, the South China Morning Post reported on Wednesday.

China Shaghai Jin Mao Tower 20107 ShutterstockShanghai, China. Shutterstock.com

"The risk of corruption in China has risen due to such factors as the increased focus by U.S. and British regulators, combined with the slowdown in China and the increased Chinese government focus on foreign and domestic entities in food and product safety as well as on the pharmaceutical industry," said Mike Murphy, the managing director of AlixPartners.

Overall, 41 percent of the respondents said corruption was unavoidable in China, while the same figure for Southeast Asia came to 54 percent, with Indonesia, the Philippines and Vietnam getting special mentions. About 80 percent of the executives at Asian companies said their industries were exposed to significant corruption risk.

"This research shows bribery and corruption are on the radar at many Asian companies," Murphy said, according to the South China Morning Post.

An older survey, by the risk consultancy Kroll, reported that 80 percent of the 901 surveyed companies reported exposure to fraud in China between 2012 and 2013, up from 69 percent a year earlier. About 20 percent of those companies said they were highly vulnerable to corruption and bribery in the 2012 to 2013 period, a huge leap from the 6 percent in the 2011 to 2012 year.

One of the biggest corruption and bribery scandals uncovered in recent years involved British drugmaker GlaxoSmithKline, which found itself at the center of a Chinese government investigation in 2013.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.